| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/26/2004 | WO2003087296A3 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167207 Synergistic mixture of vitamin k and warfarin |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
| 08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/26/2004 | US20040167131 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 08/26/2004 | US20040167081 Method for the prevention and treatment of cachexia and anorexia |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040166150 Mixture of expression vector for antihemophilic factor and lipid |
| 08/26/2004 | DE10305089A1 Neue heteroarylsubstituierte Acetonderivate als Hemmstoffe der Phospholiphase A2 New heteroaryl substituted acetone derivatives as inhibitors of phospholipase A2 |
| 08/26/2004 | DE10303229A1 α-Liponsäure, Ambroxol und/oder Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen α-lipoic acid, ambroxol and / or inhibitors of the angiotensin converting enzyme (ACE) comprehensive drug preparation and their use for the treatment of neurodegenerative diseases |
| 08/26/2004 | CA2515608A1 Stem cell factor for preventing chemotherapy-induced depletion of blood cells |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449849A2 Protease-resistant thrombomodulin analog |
| 08/25/2004 | EP1449843A1 Intermediates for the preparation of carbamoyl tetrahydropyridine derivatives |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1449529A1 Protein Kinase C Inhibitors |
| 08/25/2004 | EP1448995A1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 08/25/2004 | EP1448794A2 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448550A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 08/25/2004 | EP1448542A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade |
| 08/25/2004 | EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448150A2 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 08/25/2004 | EP1448052A1 Anti-pathogenic composition useful in blood preservation |
| 08/25/2004 | EP1448051A2 Methods and formulations for minimizing spasticity in blood vessel grafts |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1228235B1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/25/2004 | EP1185612B1 Bioreactor design and process for engineering tissue from cells |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | EP1084270B1 Methods for assaying clotting in plasma |
| 08/25/2004 | EP0854869B1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 08/25/2004 | EP0724632B1 Stem cell proliferation factor |
| 08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1523993A Antithrombogenic platiniferous ceramic composition and article containing the same |
| 08/25/2004 | CN1523992A Compositions and methods for treating amyloidosis |
| 08/25/2004 | CN1523986A Substituted oxazolidinones for combinational therapy |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523036A Anti-coagulate protein and its coding gene and high effective expression method |
| 08/25/2004 | CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/25/2004 | CN1522716A Use of compound red-rooted salvia drop pills in preparation of leucocyte adherence prohibiting drug |
| 08/25/2004 | CN1522702A Slow and control release aspirin capsule formulation and method for making same |
| 08/25/2004 | CN1163599C Anti-GPIIB/IIIA recombination antibody |
| 08/25/2004 | CN1163485C Amlodipine-series salt and preparing process and application thereof |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163272C Application of TNF antagonists as medicaments for treating septic diseases |
| 08/25/2004 | CN1163259C Tuckahoe extracts for improving hematopoietic function, medicinal composition containing same and preparing process thereof |
| 08/25/2004 | CN1163236C Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| 08/25/2004 | CN1163225C Pharmaceutical composition containing amino-acid adduct |
| 08/24/2004 | US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780878 Antithrombotic amides |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | CA2098256C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 08/19/2004 | WO2004070050A2 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | WO2004070018A2 Vegf-b and pdgf modulation of stem cells |
| 08/19/2004 | WO2004069875A2 Immunoglobulin anti integrin |
| 08/19/2004 | WO2004069862A1 Peptide conjugate |
| 08/19/2004 | WO2004069824A1 Pyrazole derivative |
| 08/19/2004 | WO2004069819A1 Novel form of simvastatin. |
| 08/19/2004 | WO2004069797A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 08/19/2004 | WO2004069254A2 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 08/19/2004 | WO2004069238A1 Drug for improving prognosis for subarachnoid hemorrhage |
| 08/19/2004 | WO2004069149A2 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 08/19/2004 | WO2004054356A3 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162417 Nucleotide sequences coding metalloenzyme for use in detergents, therapeutic, cosmetics, leather processing, solubilizing or softening agents, foods, meat modifiers, feeds and oil and fat seperating agents |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162295 Pharmaceutical compound |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162283 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 08/19/2004 | US20040162261 Double chain compound having an amino group and a carboxyl group in the hydrophilic part; forms a stable bilayer membrane vesicle in water, and a water-soluble drug can be enclosed in the internal phase of the vesicle at high efficiency |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162246 Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same |
| 08/19/2004 | US20040161822 Protein having antithrombotic activity and method for producing the same |
| 08/19/2004 | DE10237442B4 Hochverzweigte, niedrig substituierte Stärkeprodukte Highly branched, low-substituted starch products |
| 08/19/2004 | CA2515266A1 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 08/19/2004 | CA2515147A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 08/19/2004 | CA2515119A1 Pyrazole derivative |
| 08/19/2004 | CA2515102A1 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 08/19/2004 | CA2513631A1 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | CA2512051A1 Immunoglobulin |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram |